← FDA Drug Approvals (Drugs@FDA)
EMFLAZA
NDA · New Drug Application · Sponsor: PTC THERAP · Approved 2017-02-09
Drug application
- FDA Application #
NDA208685- Application type
- New Drug Application
- Brand name
- EMFLAZA
- Generic name
- DEFLAZACORT
- Active ingredients
- DEFLAZACORT
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PTC THERAP
- Manufacturer
- PTC Therapeutics, Inc.
- First approval
- 2017-02-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown